Loading…
Quest Diagnostics Incorporated is projected to rise to $254.25 by 2027, a +31% move from its current price of $193.99. DGX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $191.99 | $194.06 | $196.14 | +0.03% |
| May 30 | $191.20 | $194.12 | $197.08 | +0.07% |
| May 31 | $190.62 | $194.19 | $197.82 | +0.10% |
| Jun 1 | $190.14 | $194.25 | $198.46 | +0.14% |
| Jun 2 | $189.72 | $194.32 | $199.03 | +0.17% |
| Jun 3 | $189.35 | $194.39 | $199.55 | +0.20% |
| Jun 4 | $189.02 | $194.45 | $200.04 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $189.02 | $194.45 | $200.04 | +0.24% |
| Week 2 | $187.26 | $194.92 | $202.88 | +0.48% |
| Week 3 | $186.02 | $195.38 | $205.21 | +0.72% |
| Week 4 | $185.06 | $195.84 | $207.26 | +0.96% |
| Week 5 | $184.26 | $196.31 | $209.15 | +1.20% |
| Week 6 | $183.59 | $196.78 | $210.92 | +1.44% |
| Week 7 | $183.00 | $197.25 | $212.60 | +1.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated (DGX) is a healthcare company that provides diagnostic testing and related services in the United States. The stock is currently priced at $195.21 and sits within a marketplace context that includes a market capitalization of $21.61B and a rank of 563. The forecast suggests a bullish price trajectory over time, with average prices rising from $195.21 in 2026 to $392.09 in 2030 and reaching $1,830.22 on average by 2050, with potential maximums up to $2,994.99.
A major floor 8.9% below — a decisive break under it would weaken the trend.
The nearest floor, 3.8% below — buyers have tended to step in here.
The nearest ceiling, 5.7% above — a clean break opens room to run.
A major ceiling 10.1% above — clearing it would confirm fresh momentum.
Key DGX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DGX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $193.93 | Buy | $193.29 | Buy |
| MA 10 | $191.53 | Buy | $192.43 | Buy |
| MA 20 | $191.06 | Buy | $192.38 | Buy |
| MA 50 | $194.34 | Sell | $193.64 | Buy |
| MA 100 | $194.10 | Sell | $192.59 | Buy |
| MA 200 | $188.12 | Buy | $187.77 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.44 | Neutral |
| Stoch RSI (14) | 84.20 | Sell |
| CCI (20) | 99.95 | Neutral |
| Williams %R (14) | -14.19 | Info |
| MACD (12,26,9) | 0.74 | Buy |
| ROC (12) | 3.52 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 85.81 | Sell |
| TRIX (15) | -0.10 | Sell |
| Awesome (5,34) | 0.75 | Buy |
| Ultimate (7,14,28) | 70.58 | Sell |
| Momentum (10) | 3.81 | Buy |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 195.26 | Sell |
| ADX (14) | 10.74 | Neutral |
| ATR (14) | 1.93 | Info |
The near-term technical picture is bullish with RSI14 at 60. The stock trades above the 50-day moving average of $194.57 and above the 200-day moving average of $187.94, indicating an upward tilt. Key near-term levels are a support at $186.61 and a resistance at $205.04, framing a 30-day price range from $181.52 to $209.93.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $173.49 | $193.99 | $254.66 | 0% | Neutral | |
| $207.70 | $254.25 | $325.77 | +31% | Bullish | |
| $242.64 | $302.44 | $397.64 | +56% | Bullish | |
| $262.02 | $331.53 | $444.96 | +71% | Bullish | |
| $290.12 | $371.98 | $508.08 | +92% | Bullish | |
| $294.57 | $382.26 | $530.25 | +97% | Bullish | |
| $306.83 | $402.62 | $566.36 | +108% | Bullish | |
| $348.77 | $462.44 | $658.83 | +138% | Bullish | |
| $399.68 | $535.18 | $771.49 | +176% | Bullish | |
| $445.85 | $602.61 | $878.29 | +211% | Bullish | |
| $579.11 | $816.24 | $1,246.33 | +321% | Bullish | |
| $1,087.66 | $1,643.91 | $2,689.88 | +747% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $173.49 | $193.99 | $226.54 | +0.00% |
| June 2026 | $167.70 | $195.64 | $232.65 | +0.85% |
| July 2026 | $170.55 | $200.10 | $240.20 | +2.28% |
| August 2026 | $168.59 | $198.70 | $240.26 | -0.70% |
| September 2026 | $168.23 | $199.01 | $242.06 | +0.15% |
| October 2026 | $173.60 | $206.06 | $251.99 | +3.54% |
| November 2026 | $175.72 | $209.20 | $257.04 | +1.53% |
| December 2026 | $172.82 | $206.34 | $254.66 | -1.37% |
Click any year to see its month-by-month DGX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The DGX price prediction for 2026 points to an average of $193.99 (low $173.49, high $254.66) — a potential gain of 0% on today's $193.99. Price action looks broadly range-bound.
In 2027, DGX is projected to trade between $207.70 and $325.77, averaging $254.25 — a potential gain of +31% from today's $193.99. That is up +31% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Quest Diagnostics Incorporated's 2028 outlook centres on $302.44, within a $242.64 to $397.64 range. That is up +19% on the projected 2027 average. That marks a +56% change versus current levels. Momentum favours further upside here.
By 2029, DGX could reach as high as $444.96, with a base case around $331.53 and support toward $262.02 — roughly +71% from $193.99. Buyers look set to stay in control over this stretch.
Expect DGX to range from $290.12 to $508.08 through 2030. The $371.98 average target implies a +92% move from current prices. That is up +12% on the projected 2029 average. Momentum favours further upside here.
The DGX price prediction for 2031 points to an average of $382.26 (low $294.57, high $530.25) — a potential gain of +97% on today's $193.99. Buyers look set to stay in control over this stretch.
In 2032, DGX is projected to trade between $306.83 and $566.36, averaging $402.62 — a potential gain of +108% from today's $193.99. That is up +5% on the projected 2031 average. Momentum favours further upside here.
Quest Diagnostics Incorporated's 2033 outlook centres on $462.44, within a $348.77 to $658.83 range. That is up +15% on the projected 2032 average. That marks a +138% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, DGX could reach as high as $771.49, with a base case around $535.18 and support toward $399.68 — roughly +176% from $193.99. Momentum favours further upside here.
Expect DGX to range from $445.85 to $878.29 through 2035. The $602.61 average target implies a +211% move from current prices. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The DGX price prediction for 2040 points to an average of $816.24 (low $579.11, high $1,246.33) — a potential gain of +321% on today's $193.99. Momentum favours further upside here.
In 2050, DGX is projected to trade between $1,087.66 and $2,689.88, averaging $1,643.91 — a potential gain of +747% from today's $193.99. That is up +101% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DGX today (≈ 5.154905 DGX) could be worth
$8,474.18
+$7,474.18 (+747%) by 2050 · US Dollar
Based on the average projected DGX price of $1,643.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DGXwould be worth at today's price.
$1,000 invested in DGX on May 27, 2025 (≈ 5.757716 DGX) would be worth
$1,116.94
+$116.94 (+11.7%) today · 1.12× · US Dollar
Based on a DGX entry price of $173.68 vs. today's $193.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $193.75 | $1,001.24 | +0.1% |
| 1 month ago | $196.63 | $986.57 | -1.3% |
| 3 months ago | $211.1 | $918.95 | -8.1% |
| 6 months ago | $189.18 | $1,025.43 | +2.5% |
| 1 year ago | $173.68 | $1,116.94 | +11.7% |
| All time (5.0y) ago | $127.27 | $1,524.24 | +52.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DGX forecast.
Our base-case forecast reaches $390.00 around 2032.
Implied market cap at $390.00: $43.17B
The multi-year forecast shows meaningful upside. By 2030 the average price is projected to $392.09 with a minimum of $305.74 and a maximum of $535.68, and a 2030 ROI of 100.9% with a bullish sentiment. The path continues higher, with 2040 averaging $899.99 and a max of $1,374.36, yielding a 361% ROI and a bullish sentiment.
By 2050, the average price is projected to $1,830.22 with a maximum of $2,994.99 and a remarkable 837.6% ROI, maintaining a bullish sentiment. The 2027–2050 stretch shows rising averages and strong upside potential, but as always these are estimates, not guarantees, and market dynamics can alter outcomes.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $392.09, with a low of $305.74 and a high of $535.68, and a projected ROI of 100.9% with a bullish sentiment.
Forecasts indicate bullish sentiment from 2027 onward, with the average price rising from $263.00 in 2027 to $1,830.22 in 2050 and a cumulative ROI up to 837.6% by 2050.
Yes. The forecast shows a 2050 average of $1,830.22 and a 2050 maximum of $2,994.99, indicating potential to exceed $1,000 over the horizon.
Current price is $195.21 and market capitalization is $21.61B.
The 30-day range is from a low of $181.52 to a high of $209.93.
Quest Diagnostics Incorporated Community Discussion
0Share your Quest Diagnostics Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.